Biogen Inc Cash Flow-to-Debt Ratio
Biogen Inc cash flow-to-debt ratio. Biogen Inc (BIIB) has a Cash Flow-to-Debt Ratio of 0.03x as of June 2026, meaning its operating cash flow of $448.90 Million could theoretically repay 0% of its total liabilities ($13.24 Billion) in one year. Check BIIB operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Biogen Inc (1989–2025)
Cash flow-to-debt ratio of Biogen Inc from 1989 to 2025. Historical debt coverage capacity for Biogen Inc across 37 annual periods. Check BIIB capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Biogen Inc Cash Flow-to-Debt Ratio by Year (1989–2025)
Biogen Inc cash flow-to-debt ratio by year from 1989 to 2025. Year-by-year debt coverage analysis for Biogen Inc. For the full cash flow conversion analysis, see Biogen Inc (BIIB) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | $2.20 Billion | $11.18 Billion | ▼ -22.3% |
| 2024 | 0.25x | $2.88 Billion | $11.33 Billion | ▲ +97.5% |
| 2023 | 0.13x | $1.55 Billion | $12.05 Billion | ▲ +3.6% |
| 2022 | 0.12x | $1.38 Billion | $11.17 Billion | ▼ -56.0% |
| 2021 | 0.28x | $3.64 Billion | $12.92 Billion | ▼ -7.2% |
| 2020 | 0.30x | $4.23 Billion | $13.93 Billion | ▼ -40.4% |
| 2019 | 0.51x | $7.08 Billion | $13.90 Billion | ▲ +0.9% |
| 2018 | 0.50x | $6.19 Billion | $12.26 Billion | ▲ +22.6% |
| 2017 | 0.41x | $4.55 Billion | $11.05 Billion | ▼ -2.2% |
| 2016 | 0.42x | $4.52 Billion | $10.75 Billion | ▲ +14.7% |
| 2015 | 0.37x | $3.72 Billion | $10.13 Billion | ▼ -56.3% |
| 2014 | 0.84x | $2.94 Billion | $3.50 Billion | ▲ +16.1% |
| 2013 | 0.72x | $2.35 Billion | $3.24 Billion | ▲ +21.8% |
| 2012 | 0.59x | $1.88 Billion | $3.17 Billion | ▼ -9.9% |
| 2011 | 0.66x | $1.73 Billion | $2.62 Billion | ▲ +7.2% |
| 2010 | 0.61x | $1.62 Billion | $2.64 Billion | ▲ +31.0% |
| 2009 | 0.47x | $1.07 Billion | $2.29 Billion | ▼ -19.8% |
| 2008 | 0.59x | $1.56 Billion | $2.67 Billion | ▲ +77.5% |
| 2007 | 0.33x | $1.02 Billion | $3.09 Billion | ▼ -45.0% |
| 2006 | 0.60x | $841.27 Million | $1.40 Billion | ▼ -1.5% |
| 2005 | 0.61x | $889.50 Million | $1.46 Billion | ▲ +95.6% |
| 2004 | 0.31x | $727.99 Million | $2.34 Billion | ▲ +247.9% |
| 2003 | 0.09x | $219.21 Million | $2.45 Billion | ▼ -86.2% |
| 2002 | 0.65x | $267.08 Million | $411.57 Million | ▼ -23.6% |
| 2001 | 0.85x | $316.36 Million | $372.21 Million | ▼ -24.4% |
| 2000 | 1.12x | $365.94 Million | $325.45 Million | ▲ +23.2% |
| 1999 | 0.91x | $272.29 Million | $298.44 Million | ▲ +12.0% |
| 1998 | 0.81x | $167.84 Million | $206.10 Million | ▲ +131.5% |
| 1997 | 0.35x | $97.63 Million | $277.53 Million | ▲ +13.5% |
| 1996 | 0.31x | $46.54 Million | $150.20 Million | ▲ +182.7% |
| 1995 | 0.11x | $9.45 Million | $86.22 Million | ▼ -84.9% |
| 1994 | 0.73x | $34.89 Million | $47.93 Million | ▼ -51.4% |
| 1993 | 1.50x | $47.60 Million | $31.80 Million | ▼ -9.0% |
| 1992 | 1.65x | $43.10 Million | $26.20 Million | ▲ +293.1% |
| 1991 | 0.42x | $5.90 Million | $14.10 Million | ▼ -49.9% |
| 1990 | 0.84x | $10.70 Million | $12.80 Million | ▲ +166.9% |
| 1989 | -1.25x | $-7.50 Million | $6.00 Million | — |